SCHEDULE: Khrom Capital Boosts Stake in Acadia Healthcare to 7.74%
Beneficial Ownership Update
Khrom Capital Management and affiliates have increased their beneficial ownership in Acadia Healthcare Company, Inc. to 7.74% through recent open market purchases.
Summary
- Khrom Investments Fund, LP, Khrom Capital Management LLC, and Eric Khrom (collectively, the "Reporting Persons") have filed an Amendment No. 1 to their Schedule 13D regarding Acadia Healthcare Company, Inc. (the "Issuer").
- The Reporting Persons now beneficially own an aggregate of 7,145,239 shares of Acadia Healthcare Company, Inc. common stock.
- This represents 7.74% of the Issuer's outstanding shares, based on 92,258,166 shares as of November 4, 2025.
- Khrom Investments Fund, LP is the direct beneficial owner of 7,138,311 shares.
- Eric Khrom is the direct beneficial owner of 6,928 shares.
- Khrom Capital Management LLC and Eric Khrom are deemed to share voting and dispositive power over the shares held by Khrom Investments Fund, LP.
- Since October 1, 2025, Khrom Investments Fund, LP has made numerous open market purchases of Acadia Healthcare shares, acquiring a total of 2,300,883 shares at prices ranging from $14.3803 to $24.369 per share.
Sentiment
Score: 7
Explanation: Increased institutional ownership by Khrom Capital Management, indicating strong conviction in the company's value and prospects.
Positives
- Significant increase in beneficial ownership by Khrom Capital Management and its affiliates, indicating strong conviction in Acadia Healthcare Company, Inc.'s value and prospects.
- The aggregate beneficial ownership now stands at 7.74% of the company's common stock, signaling a substantial institutional stake.
Future Outlook
NA
Industry Context
The increased stake by Khrom Capital Management in Acadia Healthcare Company, Inc. suggests a positive outlook on the behavioral healthcare sector, which continues to see demand driven by mental health awareness and access initiatives. This move by a significant institutional investor could be interpreted as a vote of confidence in Acadia's market position and growth strategy within this specialized healthcare segment.
Stakeholder Impact
- Shareholders may view the increased institutional ownership as a positive signal, potentially leading to increased investor confidence and demand for the stock.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Original Schedule 13D filed by the Reporting Persons. |
| 10/10/2025 | Open market purchase of 44,000 shares by Khrom Investments Fund, LP at $24.369 per share. |
| 10/20/2025 | Open market purchase of 3,000 shares by Khrom Investments Fund, LP at $24.1906 per share. |
| 10/20/2025 | Open market purchase of 1,000 shares by Khrom Investments Fund, LP at $24.2759 per share. |
| 10/21/2025 | Open market purchase of 10,000 shares by Khrom Investments Fund, LP at $23.6212 per share. |
| 10/21/2025 | Open market purchase of 5,000 shares by Khrom Investments Fund, LP at $23.82 per share. |
| 10/21/2025 | Open market purchase of 4,000 shares by Khrom Investments Fund, LP at $23.775 per share. |
| 10/21/2025 | Open market purchase of 16,000 shares by Khrom Investments Fund, LP at $23.8013 per share. |
| 10/21/2025 | Open market purchase of 3,000 shares by Khrom Investments Fund, LP at $23.85 per share. |
| 10/21/2025 | Open market purchase of 2,000 shares by Khrom Investments Fund, LP at $23.65 per share. |
| 10/22/2025 | Open market purchase of 50,000 shares by Khrom Investments Fund, LP at $23.3996 per share. |
| 10/23/2025 | Open market purchase of 45,000 shares by Khrom Investments Fund, LP at $23.7664 per share. |
| 10/23/2025 | Open market purchase of 6,618 shares by Khrom Investments Fund, LP at $23.8094 per share. |
| 10/24/2025 | Open market purchase of 14,461 shares by Khrom Investments Fund, LP at $23.53 per share. |
| 10/24/2025 | Open market purchase of 2,000 shares by Khrom Investments Fund, LP at $23.5736 per share. |
| 10/24/2025 | Open market purchase of 3,749 shares by Khrom Investments Fund, LP at $23.3415 per share. |
| 10/24/2025 | Open market purchase of 8,500 shares by Khrom Investments Fund, LP at $23.4206 per share. |
| 10/24/2025 | Open market purchase of 3,000 shares by Khrom Investments Fund, LP at $23.7806 per share. |
| 10/27/2025 | Open market purchase of 5,000 shares by Khrom Investments Fund, LP at $23.3809 per share. |
| 10/27/2025 | Open market purchase of 20,000 shares by Khrom Investments Fund, LP at $23.32 per share. |
| 10/27/2025 | Open market purchase of 42,000 shares by Khrom Investments Fund, LP at $23.3642 per share. |
| 10/27/2025 | Open market purchase of 10,000 shares by Khrom Investments Fund, LP at $23.3801 per share. |
| 10/27/2025 | Open market purchase of 10,000 shares by Khrom Investments Fund, LP at $23.3653 per share. |
| 10/27/2025 | Open market purchase of 10,000 shares by Khrom Investments Fund, LP at $23.115 per share. |
| 10/27/2025 | Open market purchase of 26,707 shares by Khrom Investments Fund, LP at $23.4711 per share. |
| 10/27/2025 | Open market purchase of 42,000 shares by Khrom Investments Fund, LP at $23.5034 per share. |
| 10/27/2025 | Open market purchase of 10,000 shares by Khrom Investments Fund, LP at $22.8454 per share. |
| 10/27/2025 | Open market purchase of 2,000 shares by Khrom Investments Fund, LP at $23.2558 per share. |
| 10/27/2025 | Open market purchase of 16,699 shares by Khrom Investments Fund, LP at $23.4336 per share. |
| 10/27/2025 | Open market purchase of 30,000 shares by Khrom Investments Fund, LP at $22.9748 per share. |
| 10/27/2025 | Open market purchase of 30,000 shares by Khrom Investments Fund, LP at $23.027 per share. |
| 10/27/2025 | Open market purchase of 10,000 shares by Khrom Investments Fund, LP at $22.8548 per share. |
| 10/27/2025 | Open market purchase of 30,000 shares by Khrom Investments Fund, LP at $23.0012 per share. |
| 10/28/2025 | Open market purchase of 20,000 shares by Khrom Investments Fund, LP at $22.9862 per share. |
| 10/28/2025 | Open market purchase of 10,000 shares by Khrom Investments Fund, LP at $22.997 per share. |
| 10/30/2025 | Open market purchase of 26,000 shares by Khrom Investments Fund, LP at $22.217 per share. |
| 10/30/2025 | Open market purchase of 18,000 shares by Khrom Investments Fund, LP at $22.3469 per share. |
| 10/30/2025 | Open market purchase of 150,000 shares by Khrom Investments Fund, LP at $22.1497 per share. |
| 10/30/2025 | Open market purchase of 8,000 shares by Khrom Investments Fund, LP at $22.1602 per share. |
| 11/03/2025 | Open market purchase of 65,471 shares by Khrom Investments Fund, LP at $21.0677 per share. |
| 11/04/2025 | Date for outstanding shares count (92,258,166 shares) as reported in the Issuer's Form 10-Q. |
| 11/05/2025 | Issuer's Quarterly Report on Form 10-Q filed with the SEC. |
| 11/07/2025 | Open market purchase of 45,073 shares by Khrom Investments Fund, LP at $19.1493 per share. |
| 11/20/2025 | Date of event which required the filing of this Schedule 13D Amendment. |
| 11/20/2025 | Open market purchase of 250,000 shares by Khrom Investments Fund, LP at $14.5331 per share. |
| 11/20/2025 | Open market purchase of 36,067 shares by Khrom Investments Fund, LP at $14.3803 per share. |
| 11/21/2025 | Open market purchase of 3,037 shares by Khrom Investments Fund, LP at $14.457 per share. |
| 11/21/2025 | Open market purchase of 300,000 shares by Khrom Investments Fund, LP at $15.2559 per share. |
| 11/21/2025 | Open market purchase of 53,481 shares by Khrom Investments Fund, LP at $14.8481 per share. |
| 11/24/2025 | Open market purchase of 600,000 shares by Khrom Investments Fund, LP at $15.379 per share. |
| 11/24/2025 | Date of signing for the Schedule 13D Amendment No. 1. |
Recommendation
holdThe filing indicates a significant increase in beneficial ownership by a prominent investment firm, suggesting a strong conviction in the company's long-term value. While this is a positive signal, the filing does not provide operational or financial performance details to warrant a 'buy' or 'strong buy' recommendation. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current positions while monitoring future developments and the company's performance.
Keywords
Acadia Healthcare, AHCO, Khrom Capital, Schedule 13D, beneficial ownership, institutional investment, healthcare, behavioral health
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.